We use analytics to improve Pollar and, with your consent, the Meta pixel to measure sign-ups and purchases that come from our ads. You can change this anytime in Settings. Privacy policy

Search⌘K
HomeFor YouLiveBriefAsk
MapMarketsThreadsSoundsFilmsRadar
DomesticGeopoliticsEconomySocietyScience & TechInfrastructureSportCultureLifestyle
Support Pollar
ContactPublisher

Mark Goldsmith

Headlines and summaries are written by AI. How it works

  • 1h ago

    European Commission authorises Daraxonrasib for pretreated metastatic pancreatic cancer

    The European Commission has granted Daraxonrasib a centralised EU marketing authorisation for adults with metastatic pancreatic cancer who have had prior treatment. National agencies now negotiate reimbursement, and the drug does not cure the disease.

  • About
  • Editorial standards
  • Corrections
  • AI policy
  • Privacy
  • Terms
  • Contact

Top stories now

  • 16:14Deutsche Bank shares fall as 15 million leaked files surface
  • 15:18Trump takes Iran dirty bomb report in Washington seriously
  • 13:57Diallo, UEFA's pick, enters the FIFA presidency race

Morning Brief 05:05

Russian strikes hit Kyiv bridges
Synthetic voice (AI)
Read the Brief
HomeBriefLiveThreadsSearch